Cargando…
Defining Acute Coronary Syndrome through Metabolomics
As an emerging platform technology, metabolomics offers new insights into the pathomechanisms associated with complex disease conditions, including cardiovascular diseases. It also facilitates assessing the risk of developing the disease before its clinical manifestation. For this reason, metabolomi...
Autores principales: | Surendran, Arun, Atefi, Negar, Zhang, Hannah, Aliani, Michel, Ravandi, Amir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540033/ https://www.ncbi.nlm.nih.gov/pubmed/34677400 http://dx.doi.org/10.3390/metabo11100685 |
Ejemplares similares
-
Metabolomic characterization of myocardial ischemia-reperfusion injury in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention
por: Surendran, Arun, et al.
Publicado: (2019) -
Lipidomic Predictors of Coronary No-Reflow
por: Surendran, Arun, et al.
Publicado: (2023) -
Impact of myocardial reperfusion on human plasma lipidome
por: Surendran, Arun, et al.
Publicado: (2022) -
Lipidomics of Bioactive Lipids in Acute Coronary Syndromes
por: Solati, Zahra, et al.
Publicado: (2019) -
Postpartum Endocarditis and Left Main Embolization
por: Atefi, Negar, et al.
Publicado: (2022)